TABLE 1 Summary of the Clinical and Histopathologic Characteristics of the 26 Barrett’s-Associated Esophageal Adenocarcinomas

From: Molecular Genetic Changes in Metastatic Primary Barrett’s Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett’s Adenocarcinoma

Case

Age (y)/Sex

TNMa

Stagea

G

R

Status

Survival (mo)

1

62/M

pT1 pN0 (0/10) M0

I

3

0

NA

NA

2

61/M

pT1 pN0 (0/23) M0

I

3

0

Alive

36

3

60/M

pT1 pN0 (0/32) M0

I

2

0

NA

NA

4

72/M

pT1 pN0 (0/20) M0

I

2

0

Alive

41

5

72/M

pT1 pN0 (0/25) M0

I

3

0

Alive

21

6

70/M

pT1 pN0 (0/30) M0

I

2

0

Alive

29

7

72/M

pT1 pN0 (0/29) M0

I

4

0

Dead

0

8

34/M

pT1 pN0 (0/4) M0

I

2

0

Alive

15

9

70/M

pT1 pN0 (0/2) M0

I

3

0

Dead

4

10

76/M

pT1 pN0 (0/13) M0

I

2

0

Alive

85

11

50/M

pT1 pN0 (0/19) M0

I

3

0

Alive

19

12

62/M

pT1 pN0 (0/22) M0

I

2

0

Alive

7

13

68/M

pT1 pN0 (0/29) M0

I

2

0

Alive

4

14

59/M

pT1 pN0 (0/14) M0

I

2

0

Alive

71

15

75/M

pT1 pN0 (0/19) M0

I

3

0

Alive

40

16

79/M

pT1 pN0 (0/13) M0

I

3

0

Dead

1

17

55/M

pT1 pN0 (0/12) M0

I

2

0

Alive

1

18

58/M

pT3 pN0 (0/17) M0

II

1

0

Alive

23

19

62/F

pT1 pN1 (1/13) M0

II

4

0

Dead

31

20

68/M

pT2 pN1 (2/18) M0

II

3

0

Dead

14

21

53/M

pT3 pN1 (4/11) M0

III

2

1

Dead

0

22

75/M

pT3 pN1 (2/27) M0

III

3

0

Alive

8

23

65/M

pT3 pN1 (2/14) M0

III

3

0

Dead

43

24

55/M

pT3 pN1 (8/31) M0

III

3

x

Dead

27

25

75/M

pT2 pN1 (5/10) pM1a LYM (1/3)

IV

3

0

Alive

11

26

58/M

pT1 pN0 (0/15) pM1a (LYM 2/3)

IV

2

0

Dead

1

  1. M, male; F, female; G, histologic tumor differentiation grade; R, residual tumor; NA, data not available.
  2. aAccording to UICC system.
Back to article page